A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Abingdon Health Announces Its Latest Expansion and Additional Manufacturing Capacity

Abingdon Health announced further expansion at its York headquarters in the UK, following further investment in state-of-the-art lateral flow automation.

Abingdon Health explains this will provide a significant increase in its manufacturing footprint, resulting in Europe’s largest capacity for rapid test manufacturing.

This news comes weeks after the UK Government announced Abingdon Health as one of the leading members of the UK Rapid Test Consortium (UK-RTC).

Earlier this year, the company announced a preliminary round of expansion in York after 90 % revenue growth in 2019, thanks to new assay developments and assay manufacturing contract wins, and the introduction of its AppDx Smartphone reader software. In April 2020, growth continued with the acquisition of a new lateral flow manufacturing facility in Doncaster, UK. This latest expansion and investment in equipment, which has been captured in a new video, comes as 2020 sees continuing high demand for Abingdon Health’s services.

Abingdon Health’s two manufacturing sites in York and Doncaster have the capacity to produce millions of rapid tests per month for clients across many industries. This adaptable, dual-site approach forms a peace-of-mind solution that assures customers receive product consistency and a security of supply during routine scheduling and spikes in demand.

Michael Hunter, Operations Director of Abingdon Health, commented: “The additional footprint and automation come at a timely moment as demand for rapid tests is growing rapidly, with the market likely to exceed $10bn globally. Our precision automation and multi-site approach means we can adapt to meet the varying manufacturing needs of our growing global client base.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The company announced the launch of validated antibodies for rare cell and circulating tumor cell (CTC) enumeration. Validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits, the antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of tumor heterogeneity and disease progression at various stages.
Proteintech advises the new building houses research and development, production, logistics and administration in an area more than three times larger than its previous space.
In September 2023, Seegene and Springer Nature opened applications to scientists and experts across the global community to conduct research for the 15 designated projects to develop Seegene's syndromic qPCR diagnostics assay reagents for the Open Innovation Program.
Lindus Health has taken learnings from this experience to build a bespoke "All-in-One Metabolic CRO" offering that combines the expertise of a seasoned full service CRO and internal site/PI expertise with a distinctive technology driven approach on its proprietary Citrus™ platform. This unique marriage of technology and services sets metabolic sponsors up to run faster, more patient-centric clinical trials.
The addition of Olink to the Synexa Life Sciences technology portfolio demonstrates our continued commitment to strengthening our biomarker and bioanalysis capabilities across several expertise areas including oncology, immuno-oncology, infectious diseases and more.

By using this website you agree to accept Medical Device News Magazine Privacy Policy